濮阳东方妇科医院治病不贵濮阳东方医院男科治疗阳痿口碑好很不错,濮阳东方妇科评价,濮阳东方医院治疗早泄非常靠谱,濮阳东方上班到几点,濮阳东方医院男科看早泄价格正规,濮阳东方医院男科看阳痿收费低,濮阳东方医院男科治疗阳痿费用

SYDNEY, June 29 (Xinhua) -- A type of dried seaweed sold in Asian food supermarkets in Australia has been recalled after it was found to have high levels of iodine dangerous to pregnant women, local media reported on Wednesday.Food Standards Australia New Zealand (FSANZ) has ordered the recall of Wang Dried Kelp Varech Speche, a Korean brand of the dried seaweed, according to Australian Associated Press (AAP).It has been available in Asian grocery stores and restaurants in the Brisbane and Gold Coast areas of Queensland."The product contains high levels of naturally occurring iodine," FSANZ said in a statement."Regular consumption of these products may cause health problems in some people including pregnant and breastfeeding women."FSANZ said consumers concerned about their health should seek medical advice and should return the products to the place of purchase for a full cash refund.

SAN FRANCISCO, June 13 (Xinhua) -- Google on Monday confirmed that it had signed an agreement to buy Admeld, an on-line advertising optimization firm, in a deal seen as the Internet search giant's latest move to bolster its on-line display ad business.Admeld, launched in 2007 and headquartered in New York City, has developed a service that can help on-line publishers manage their ad space more efficiently and profitably.Admeld now has more than 500 customers worldwide, among them are FOX News, IDG TechNetwork, Discovery and The Weather Channel, according to information posted on its website."By combining Admeld's services, expertise and technology with Google's offerings, we're investing in what we hope will be an improved era of flexible ad management tools for major publishers, " Neal Mohan, Google's vice president of display advertising, said in a blog post announcing the deal."We believe that this investment will be an important step to help on-line publishers, and will further improve and grow the display advertising industry as a whole," Mohan noted.On-line display ads usually appear in forms that consist of images and may be interactive. According to the Interactive Advertising Bureau, a U.S. trade association, display-related on- line ad revenue in the United States totaled nearly 10 billion U.S. dollars in 2010.Financial terms of the deal were not disclosed by the two companies. TechCrunch, a technology blog site, has reported that Google paid around 400 million dollars.

BEIJING, July 13 (Xinhuanet) -- Gasoline powers vehicles all around the world, but a sick Chinese man has been drinking the sticky liquid for 42 years under the illusion that it can relieve his physical pain.Chen Dejun, 71, lives by himself in shabby thatched cottage on a hill in Shuijiang township, Nanchuan district of southwest China's Chongqing municipality. The short and bony man said he drinks 3 to 3.5 kilograms of gasoline every month, which he buys from a station at the foot of the hill.Chen is known locally as a stonecutter and master of weaving bamboo with a good business sense. But he’s also known for his undying love of drinking gasoline.He developed the habit back in 1969 when he suddenly began coughing and felt pain in his chest. Seeing no progress after trying some medicine, he took up the folk remedy of drinking kerosene, Chongqing Evening News reported.It turned out to be helpful for him after the first sip, and he since became addicted to kerosene. Then he moved on to gasoline.Chen said it is hard to calculate exactly how much gasoline he has swallowed throughout his life, but the newspaper reported Chen has consumed an estimated 1.5 tons over the past 42 years.Chen's wife Yuan Huibi and their three sons tried many times to stop Chen's addiction to gasoline, but those efforts only made the family relations tense. Eight years ago Chen moved to the cottage to live alone.Sources from Honglou Hospital in Chongqing said Chen‘s health is fine despite having symptoms of emphysema. Chen refused to receive free check ups from the hospital.Feng Fu, an associate professor with the Second Hospital Affiliated to Chongqing Medical University, said Chen may have developed some resistance to gasoline. Otherwise, Feng said, it would be impossible for Chen to live. Feng also said gasoline may only work as anaesthetic for Chen but can’t cure his pain.

BEIJING, July 27 (Xinhuanet) -- Amazon.com’s e-book reader Kindle 3G with special offers is now the company’s top-selling e-book device, according to media reports on Wednesday.Amazon revealed in its quarterly earnings report that the ad-supported version costs 139 U.S. dollars,  50 dollars cheaper than the comparable Kindle 3G, and costs the same as a Kindle with Wi-Fi connectivity. Many believe Kindle is the most popular dedicated e-book device on the market today.The advertisements will appear only in screensavers (which appear when the reader is in an idle state) and at the bottom of the home screen, so they don’t interrupt readers.“Since AT&T agreed to sponsor screensavers, Kindle 3G with Special Offers is now our bestselling Kindle device,” Amazon’s press release said.Having zoomed past the earlier Sony Reader, and kicked off a wave of competition including the Barnes & Noble Nook and the Kobo E-Reader, Kindle is believed the most popular dedicated e-book device on the market today.

WELLINGTON, June 7 (Xinhua) -- Scientists in New Zealand have developed a new drug to fight previously untreatable hypoxic cancer tumors, which form in areas of the body starved of oxygen.The researchers at the Auckland University have entered an agreement for the clinical development of CEN-209, which was developed over 10 years of research, said a statement from the university Tuesday.CEN-209 was designed to enhance the effectiveness of radiotherapy and chemotherapy in solid hypoxic tumors, which were resistant to standard cancer therapies, said the statement. In lung cancer patients for example, about half of tumors had hypoxic regions.The new drug worked by damaging the DNA of hypoxic cancer cells, while leaving normal, healthy tissues alone.CEN-209 was designed and created by researchers at the university's Auckland Cancer Society Research Centre (ACSRC), using computer models of drug transport within tumors to accurately predict the anti-tumor activity of the drugs."Our computer models of drug transport developed in-house allowed the synthetic chemists to test their design theories and considerably shortened the discovery process," said Associate Professor Michael Hay, who led the ACSRC research chemists."CEN-209 improves markedly on previous agents in this class in terms of its ability to penetrate tumors, and this is reflected by its improved activity in the laboratory, when combined with long or short courses of radiotherapy," said researcher Professor Bill Wilson.Under the agreement between the university's Auckland UniServices Ltd. and California-based Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc., Centella will have exclusive rights to CEN-209, which it will develop and trial with Cancer Research UK.The work on CEN-209 is the culmination of a program initiated with funding from the U.S. National Cancer Institute, and more recently from the Maurice Wilkins Centre for Biodiscovery. Ongoing preclinical research on CEN-209 and a backup compound was funded by grants from the Auckland Medical Research Foundation, Genesis Oncology Trust and Health Research Council of New Zealand, said the statement.